FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anne Hammer

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Physiology

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Victor Biton; Paul T Caldwell; Anne E Hammer; Dean Naritoku; Bassel F Shneker; Alain Vuong; John A Messenheimer
Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials.
Jacqueline A French; Anne E Hammer; Alain Vuong; John A Messenheimer
Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies.
Jacqueline A French; Anne E Hammer; Bassel F Shneker; Nancy R Temkin; Paul T Caldwell; John A Messenheimer
Lamotrigine XR conversion to monotherapy: first study using a historical control group.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anne Hammer (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Victor Biton; Paul T Caldwell; Anne E Hammer; Dean Naritoku; Bassel F Shneker; Alain Vuong; John A Messenheimer
Long-term tolerability and safety of lamotrigine extended-release: pooled analysis of three clinical trials.
Clinical drug investigation 2013;33(5):359-64.
2012: Jacqueline A French; Anne E Hammer; Alain Vuong; John A Messenheimer
Analysis of three lamotrigine extended-release clinical trials: comparison of pragmatic ITT and LOCF methodologies.
Epilepsy research 2012;101(1-2):141-7.
2012: Jacqueline A French; Anne E Hammer; Bassel F Shneker; Nancy R Temkin; Paul T Caldwell; John A Messenheimer
Lamotrigine XR conversion to monotherapy: first study using a historical control group.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2012;9(1):176-84.
2008: Debra J Tompson; Imran Ali; Ruth Oliver-Willwong; Sarah Job; Li Zhu; Francesca Lemme; Anne E Hammer; Alain Vuong; John A Messenheimer
Steady-state pharmacokinetics of lamotrigine when converting from a twice-daily immediate-release to a once-daily extended-release formulation in subjects with epilepsy (The COMPASS Study).
Epilepsia 2008;49(3):410-7.
2008: Kenneth C Mills; Joseph F Drazkowski; Anne E Hammer; Paul T Caldwell; Robert P Kustra; David E Blum
Relative influences of adjunctive topiramate and adjunctive lamotrigine on scanning and the effective field of view.
Epilepsy research 2008;78(2-3):140-6.
2008: Toufic A Fakhoury; J Mitchell Miller; Anne E Hammer; Alain Vuong
Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
Drugs & aging 2008;25(11):955-62.
2007: Robert J Baumann; Toufic A Fakhoury; Robert P Kustra; Alain Vuong; Anne E Hammer; John A Messenheimer
Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Current medical research and opinion 2007;23(10):2461-5.
2007: Marianne Silver; David Blum; Joanne Grainger; Anne E Hammer; Steve Quessy
Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain.
Journal of pain and symptom management 2007;34(4):446-54.
2007: Bradley K Evans; Robert P Kustra; Anne E Hammer
Assessment of tolerability in elderly patients: changing to lamotrigine therapy.
The American journal of geriatric pharmacotherapy 2007;5(2):112-9.
2007: Toufic A Fakhoury; John J Barry; J Mitchell Miller; Anne E Hammer; Alain Vuong
Lamotrigine in patients with epilepsy and comorbid depressive symptoms.
Epilepsy & behavior : E&B 2007;10(1):155-62.
2007: Alan Ettinger; Robert P Kustra; Anne E Hammer
Effect of lamotrigine on depressive symptoms in adult patients with epilepsy.
Epilepsy & behavior : E&B 2007;10(1):148-54.
2006: Edwin Trevathan; Susan P Kerls; Anne E Hammer; Alain Vuong; John A Messenheimer
Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Pediatrics 2006;118(2):e371-8.
2006: Jerry R McKee; Theodore R Sunder; Alain Vuong; Anne E Hammer
Adjunctive lamotrigine for refractory epilepsy in adolescents with mental retardation.
Journal of child neurology 2006;21(5):372-9.
2006: Theodore R Sunder; Jerry R McKee; Anne E Hammer; Alain Vuongc
Efficacy and tolerability of adjunctive lamotrigine for refractory epilepsy in institutional or community residents with mental retardation.
Current medical research and opinion 2006;22(4):693-702.
2005: Victor Biton; J C Sackellares; Alain Vuong; Anne E Hammer; PS Barrett; John A Messenheimer
Double-blind, placebo-controlled study of lamotrigine in primary generalized tonic-clonic seizures.
Neurology 2005;65(11):1737-43.
2005: Robert P Kustra; Kimford J Meador; Bradley K Evans; Lisa M Leschek-Gelman; Dawn A Groenke; Anne E Hammer; Kevin P Nanry; John A Messenheimer
Lamotrigine therapy in patients requiring a change in antiepileptic drug regimen.
Seizure : the journal of the British Epilepsy Association 2005;14(4):254-61.
2005: Mark E Sale; Shankar Natarajan; Victor Biton; Alain Vuong; Anne E Hammer; John A Messenheimer; David Blum
A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Epilepsy & behavior : E&B 2005;6(1):63-70.
2004: Joyce A Cramer; Anne E Hammer; Robert P Kustra
Improved mood states with lamotrigine in patients with epilepsy.
Epilepsy & behavior : E&B 2004;5(5):702-7.
2004: Toufic A Fakhoury; Anne E Hammer; Alain Vuong; John A Messenheimer
Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Epilepsy & behavior : E&B 2004;5(4):532-8.
2004: George L Morris; Anne E Hammer; Robert P Kustra; John A Messenheimer
Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Epilepsy & behavior : E&B 2004;5(4):509-12.
2004: Joyce A Cramer; Anne E Hammer; Robert P Kustra
Quality of life improvement with conversion to lamotrigine monotherapy.
Epilepsy & behavior : E&B 2004;5(2):224-30.
2003: Leonard Kaminow; James R Schimschock; Anne E Hammer; Alain Vuong
Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Epilepsy & behavior : E&B 2003;4(6):659-66.
2003: Jerry R McKee; Theodore R Sunder; R FineSmith; Alain Vuong; J A Varner; Anne E Hammer; PS Barrett
Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation.
Epilepsy & behavior : E&B 2003;4(4):386-94.
2003: Victor Biton; Paul Levisohn; Sheri Hoyler; Alain Vuong; Anne E Hammer
Lamotrigine versus valproate monotherapy-associated weight change in adolescents with epilepsy: results from a post hoc analysis of a randomized, double-blind clinical trial.
Journal of child neurology 2003;18(2):133-9.
2001: Victor Biton; W Mirza; Georgia Montouris; Alain Vuong; Anne E Hammer; PS Barrett
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Neurology 2001;56(2):172-7.